Literature DB >> 3097648

Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro.

R P Saneto, A Altman, R L Knobler, H M Johnson, J de Vellis.   

Abstract

In the immune system, T-lymphocyte proliferation depends on interleukin 2 [IL-2 (T-cell growth factor)] interaction with specific receptors. In this study we show that IL-2 can specifically inhibit the proliferation of neonatal rat oligodendrocyte progenitor cells cultured in a serumless, chemically defined medium (oligodendrocyte-defined medium; ODM). IL-2 inhibited both [3H]thymidine incorporation and increase in cell number. Specificity was shown by precipitating IL-2 activity with anti-IL-2 antiserum. Furthermore, growth inhibition depended on the expression of Tac (an anti-IL-2 receptor monoclonal antibody)-positive receptors (IL-2 receptor). When cells were cultured in the presence of IL-2, both Tac-positive staining and growth inhibition were no longer expressed. The addition of interleukin 1 had no effect on [3H]thymidine incorporation or changes in cell number. However, when IL-1 was subsequently added together with IL-2, Tac expression and IL-2-mediated inhibition of cell proliferation was induced. This inhibitory effect was not due to a sensitive subpopulation because greater than 90% of the culture was Tac positive. Taken together, these data show that IL-2 can specifically inhibit oligodendrocyte proliferation and acts via Tac-positive receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097648      PMCID: PMC387107          DOI: 10.1073/pnas.83.23.9221

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  beta-Endorphin enhances lymphocyte proliferative responses.

Authors:  S C Gilman; J M Schwartz; R J Milner; F E Bloom; J D Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

2.  A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.

Authors:  M C Raff; R H Miller; M Noble
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

Review 4.  T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors.

Authors:  H Wagner; C Hardt; K Heeg; K Pfizenmaier; W Solbach; R Bartlett; H Stockinger; M Röllinghoff
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 5.  Role of lymphokine and antigen in the control of specific T cell responses.

Authors:  K J Lafferty; L Andrus; S J Prowse
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  Astrocytes, ependymal cells, and oligodendrocytes develop on schedule in dissociated cell cultures of embryonic rat brain.

Authors:  E R Abney; P P Bartlett; M C Raff
Journal:  Dev Biol       Date:  1981-04-30       Impact factor: 3.582

7.  Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

Authors:  A Fontana; F Kristensen; R Dubs; D Gemsa; E Weber
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

8.  Regulation of the in vitro antibody response by neuroendocrine hormones.

Authors:  H M Johnson; E M Smith; B A Torres; J E Blalock
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Multiple sclerosis: distribution of T cell subsets within active chronic lesions.

Authors:  U Traugott; E L Reinherz; C S Raine
Journal:  Science       Date:  1983-01-21       Impact factor: 47.728

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  12 in total

1.  Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration.

Authors:  S Eitan; R Zisling; A Cohen; M Belkin; D L Hirschberg; M Lotan; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Cytokines reduce toxic effects of ethanol on oligodendroglia.

Authors:  Joyce A Benjamins; Liljana Nedelkoska; Robert P Lisak; John H Hannigan; Robert J Sokol
Journal:  Neurochem Res       Date:  2011-01-29       Impact factor: 3.996

3.  Spontaneous production of interleukin-2 and interleukin-3 by spleen cells from mice infected with mouse hepatitis virus type 4.

Authors:  S Kyuwa; K Yamaguchi; M Hayami; J Hilgers; K Fujiwara
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes.

Authors:  B Soliven; S Szuchet; D J Nelson
Journal:  J Membr Biol       Date:  1991-11       Impact factor: 1.843

5.  Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.

Authors:  T Palomares; A Alonso-Varona; A Alvarez; B Castro; Y Calle; P Bilbao
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

6.  Interleukin 2 receptor beta chain expressed in an oligodendroglioma line binds interleukin 2 and delivers growth signal.

Authors:  Y Okamoto; S Minamoto; K Shimizu; H Mogami; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Myelin basic protein does not have a mitogenic effect on adult oligodendrocytes.

Authors:  G R Moore; S U Kim; E Chang; M Kim
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.

Authors:  M K Sharief; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

9.  Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2.

Authors:  M Katano; T Matsuo; T Morisaki; K Naito; F Nagumo; E Kubota; M Nakamura; T Hisatsugu; J Tadano
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

10.  The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines.

Authors:  T E Reichert; Y Kashii; J Stanson; A Zeevi; T L Whiteside
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.